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Summary
We have previously reported that the endocannabi-
noid, 2-arachidonoyl-glycerol (2-AG), is hydrolyzed in
rat cerebellar membranes by monoglyceride lipase
(MGL)-like enzymatic activity. The present study
shows that, like MGL, 2-AG-degrading enzymatic ac-
tivity is sensitive to inhibition by sulfhydryl-specific
reagents. Inhibition studies of this enzymatic activity
by N-ethylmaleimide analogs revealed that analogs
with bulky hydrophobic N-substitution were more po-
tent inhibitors than hydrophilic or less bulky agents.
Interestingly, the substrate analog N-arachidonylma-
leimide was found to be the most potent inhibitor. A
comparison model of MGL was constructed to get a
view on the cysteine residues located near the bind-
ing site. These findings support our previous conclu-
sion that the 2-AG-degrading enzymatic activity in rat
cerebellar membranes corresponds to MGL or MGL-
like enzyme and should facilitate further efforts to de-
velop potent and more selective MGL inhibitors.
Introduction
2-arachidonoyl-glycerol (2-AG), a monoglyceride of
arachidonic acid esterified at the sn-2 position, has
been identified as an endogenous ligand for both CB1
and CB2 cannabinoid receptors [1, 2]. 2-AG has been
reported to be the most abundant endocannabinoid in
rat brain [1, 2] and is produced by neurons “on de-
mand” and acts near the site of its synthesis. Formation
of 2-AG is mediated by phospholipase C and diacyl-
glycerol lipase [2]. Hydrolysis of 2-AG can be mediated
either by monoglyceride lipase (MGL) or fatty acid am-
ide hydrolase (FAAH), giving arachidonic acid and glyc-
erol. Moreover, 2-AG can also be metabolized by
COX-2 but not COX-1 to form prostaglandin 2-glyceryl
esters [3].
Several studies have shown that 2-AG can be hy-
drolyzed by FAAH, which is also the enzyme responsi-
ble for the hydrolysis of the first identified endocanna-
binoid, N-arachidonoyl-ethanolamide [4–7]. However,
more recent evidence supports the role of MGL, rather
than FAAH, in the biological inactivation of 2-AG. Dinh
and coworkers found that overexpression of MGL in rat
cortical neurons diminished the accumulation of 2-AG*Correspondence: susanna.saario@uku.fi[8]. Recently, they reported that RNA interference-medi-
ated silencing of MGL expression enhanced accumula-
tion of 2-AG in HeLa cells [9]. Additionally, although ser-
ine hydrolase inhibitors phenylmethylsulphonyl fluoride
(PMSF; IC50 155 M) and methyl arachidonylfluoro-
phosphonate (MAFP; IC50 2.2 nM) efficiently inhibited
2-AG degradation in rat cerebellar membranes, potent
FAAH inhibitors, such as OL-53 and URB597, were
found to be inactive in our previous study [10].
MGL is a serine hydrolase that assures complete hy-
drolysis of monoglycerides formed by the action of hor-
mone-sensitive lipase and lipoprotein lipase [11]. MGL
hydrolyzes medium- and long-chain fatty acids, such
as palmitic acid, oleic acid, and arachidonic acid from
the sn-2 position of monoglycerides, with the highest
hydrolysis rate for arachidonic acid [12–14]. MGL
mRNA has been found in rat adipose tissue, kidney,
testis, brain, adrenal gland, lung, ovary, heart, and skel-
etal muscle [15]. Recently, Dinh et al. [8] reported that
the mRNA for MGL is heterogeneously expressed in the
rat brain with highest levels in cerebellum, cortex, and
hippocampus. They also cloned MGL from a rat brain
cDNA, which had 303 amino acids and a molecular
weight of 33,367 Da. Karlsson et al. [15] also identified
a lipase-specific catalytic triad (Ser122, Asp239, and
His269) from mouse adipocyte MGL by site-directed
mutagenesis experiments.
Previous studies have demonstrated that MGL is
sensitive to inhibition by p-chloromercuribenzoic acid
(pCMB), mercury chloride (HgCl2), and N-ethylmalei-
mide (NEM) [16, 17], suggesting the presence of an
essential sulfhydryl group(s) for catalytic activity. The
aim of the present study was to characterize and local-
ize a putative NEM-sensitive site on the enzyme by
studying the sensitivity of MGL-like enzyme toward
NEM analogs with varying N-substitution in rat cerebel-
lar membrane preparation under previously described
conditions [10]. Furthermore, in the absence of an ex-
perimentally determined structure of rat MGL, a com-
parison model for the enzyme was constructed to gain
a better perspective on the 3D structural location of the
putative MGL sulfhydryl groups. Finally, the sensitivity
of MGL-like activity to the inhibition by S-nitrosothiols
and other types of NO donors was investigated.
Results
In Vitro Studies
MGL-like activity in rat cerebellar membranes was in-
hibited by pCMB, HgCl2, and NEM with IC50 values of
72 ± 8 M, 42 ± 13 M, and 53 ± 7 M, respectively.
The olefinic double bond in NEM is highly susceptible
to nucleophilic attack by sulfhydryl group, which con-
fers thiol reactivity to the molecule. Maleimide and suc-
cinimide, a ring-saturated analog of maleimide that is,
thus, incapable of serving as a Michael acceptor, were
studied for MGL inhibition activity to confirm the inhibi-
tion mechanism. It was observed that maleimide inhib-
ited MGL-like activity with an IC value of 70 M,50
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4ity at 10 mM (Table 1). Eight N-alkyl/aryl maleimides of
diverse hydrophobicity and size were examined for (
Itheir ability to inhibit MGL-like enzyme in rat cerebellar
membranes to gain more information on the NEM-sen- w
hsitive site and to probe the enzyme structure (Table 1
and Figure 1). N-Phenylmaleimide (NPhM), N-cyclohex- wTable 1. IC50 Values for the Inhibition of MGL-like Enzyme Activity in Rat Cerebellar Membranes by Various Maleimides and Succinimides
Values represent mean ± SEM from three independent experiments performed in duplicate.lmaleimide (NCM), N-propylmaleimide (NPrM), and
-(N-maleimido)benzyl-α-trimethylammonium iodide
MBTA) inhibited 2-AG hydrolysis with almost identical
C50 values (44 to 68 M). N-hydroxymaleimide (NHM),
hich is a more hydrophilic compound than NEM, in-
ibited 2-AG degradation with an IC50 value of 413 M,
hich is approximately eight times less potent than
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651Figure 1. Inhibition of MGL-like Enzymatic Activity by NHM, NEM,
NPyrM, and NAM in Rat Cerebellar Membranes
The remaining enzyme activity in the absence of inhibitors in the
control samples was expressed as 100%. The enzyme activity in
the control samples was 20 ± 1 nmol , min−1 , mg protein−1
(mean ± SEM, n = 3). The data is represented as means ± SD of
remaining enzyme activity (%) from three independent experiments
performed in duplicate.NEM. N-(1-pyrenyl)maleimide (NPyrM), a more lipo-
philic and bulkier compound compared to the above-
mentioned maleimides, inhibited MGL-like activity with
approximately six times higher potency (IC50 9.2 M)
than NEM. Interestingly, N-arachidonylmaleimide (NAM),
a compound having the most structural similarity to the
natural MGL substrate 2-AG, was w380 times more po-
tent than NEM with an IC50 value of 140 nM. To confirm
that inhibition by NAM was due to the Michael addition
reaction, N-arachidonylsuccinimide (NAS) was synthe-
sized and tested against MGL-like activity at 1 mM con-
centration, and no inhibition was observed (Table 1).
Additionally, the enzyme inhibition by NAM was not re-
versed by washing NAM-preincubated membranes
three times with 1 ml of Tris-HCl buffer (50 mM [pH 7.4],
1 mM EDTA, and 0.5% BSA) prior to incubation (90 min
at 25°C) with 2-AG. This finding further supports the
formation of a covalent linkage between the enzyme
and NAM. It is worth noting that the maximum inhibition
achieved by any of these studied maleimides was
w85%. The possible interactions of maleimide probes
with the substrate (2-AG or 1[3]-AG) were excluded by
confirming that the retention times of 2-AG or 1(3)-AG
in the HPLC chromatograms showed no differences be-
tween the samples incubated with or without malei-
mides.
A previous study demonstrated that 2-AG is metabo-
lized by COX-2 to prostaglandin glycerol esters [3]. Var-
ious COX-2 inhibitors, including nimesulide, indometh-
acin, acetylsalicylic acid, and ibuprofen, were tested at
100 M in rat cerebellar membranes. However, no inhi-
bition of 2-AG degradation was observed (data not
shown). Furthermore, a possible role of COX-2 in 2-AG
inactivation was excluded because the COX-2 inhibi-
tors did not affect the sum of peak areas of 2-AG, 1(3)-
AG, or arachidonic acid when compared to the control,
which did not contain any COX-2 inhibitors, after 90
min of incubation.
The involvement of sulfhydryl-sensitive mechanismsin the enzymatic inactivation of 2-AG raises the possi-
bility that cysteine residues could serve as potential
targets for reversible modulation by S-nitrosylation. We
investigated this possibility by treating rat cerebellar
membranes with S-nitrosoglutathione (GSNO) and
S-nitrosocysteine (CysNO), as well as the NO donor so-
dium nitroprusside (SNP). However, no effect on 2-AG
degradation was observed by any of these compounds
when tested up to 300–1000 M concentrations (data
not shown).
Molecular Modeling
When the first known MGL was sequenced, it was
found to be distantly related to various microbial en-
zymes such as haloperoxidases, esterases, and lyso-
phospholipases [15]. All these proteins, often even be-
ing seemingly nonhomologous with each other, share a
similar tertiary fold, the so-called α/β hydrolase fold
[18], which is also typical for many lipases [19]. Thus,
modeling the core β sheet and the α helices packing
against the sheet was relatively straightforward. Also,
the catalytic triad Ser122-Asp239-His269 was well lo-
cated because of the structural conservation of neigh-
boring residues. Many lipases have been shown to
have a helical segment, or lid, covering the active site
[19]. In the crystal structure of chloroperoxidase L, for
example, this lid is composed of four helices. Even
though this part of the sequence is highly variable
among the enzymes, the secondary structure predic-
tion for the MGL sequence offers the possibility that
MGL could have a lid comprised of four helices.
Karlsson and coworkers [15] have constructed a par-
tial 3D model for MGL with the X-ray structure of bro-
moperoxidase A2 from Streptomyces aureofaciens as
a template (pdb1bro) [20]. Similarly, they identified the
catalytic triad, but the highly variable sequence region
was obviously left out of the model.
According to the CYSPRED program [21], there are
no disulfide bridges in MGL. Cysteines 32 and 55 are
located in structurally conserved areas: Cys32 in the β2
strand and Cys55 at the beginning of the first helix (see
Figure 2). Cysteines 201 and 208 are located in a highly
variable region and are predicted to be at the end of
the α6 helix and at the beginning of the α7 helix,
respectively. Interestingly, Cys242 was found to be in a
well-defined loop and in proximity to the catalytic triad
(see Figure 3). Cys301 is situated at the end of the C
terminus and, thus, left out of the model. A SYBYL
MOLCAD surface (SYBYL v.6.9.2, Tripos Associates,
Inc.) calculated for our model revealed a cavity at the
bottom of which is the catalytic site. Cys208 is at the
other end of this putative substrate binding cavity.
The ROBETTA server (see Experimental Procedures)
produced five predicted rat MGL models that were
comparable with each other by using chloroperoxidase
F from Pseudomonas fluorescens (pdb1a8s) as a tem-
plate for the largest part of the enzyme. In all these
models, the catalytic triad and the cysteines are in the
places comparable to our own model.
Also, the results from FUGUE (see Experimental Pro-
cedures) confirmed that our template choice and mod-
eling alignment were reasonable. According to FUGUE,
the haloperoxidase consensus structure was the sec-
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652Figure 2. Modeling Alignment for the Sequences of Rat MGL and Chloroperoxidase L from Streptomyces lividans
Highly conserved residues are marked in black (identical residues) and light gray (conservatively replaceable residues). Cysteines in the rat
MGL sequence (Q8R431) are highlighted with a dark gray background. Boxed regions denote the amino acid coordinates transferred from
the chloroperoxidase X-ray structure (1A88) onto the MGL model. N and C termini were left out of the model. Predicted and experimentally
determined secondary structures for rat MGL and chloroperoxidase L, respectively, are denoted by the letters E (β sheet) and H (α helix). β
sheets and α helices are numbered according to the chloroperoxidase crystal structure. The residues of the catalytic triad are marked with
an inverted triangle (;).mour model.
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mDistances between the residues are presented in Ångströms. Color
code: gray, carbon; red, oxygen; blue, nitrogen; cyan, hydrogen;
yellow, sulfur; magenta, α helix; green, β strand; orange, loop/coil. lond best template (Z score, 23.65) after a bacterial car- D
boxylesterase structure (pdb1r1d; Z score, 24.30), and
Pboth of these templates had a similar α/β hydrolase fold
Mof the core enzyme. Only the variable lid area of the
etemplates was somewhat different. Therefore, in the rough
Irat MGL models based on these templates, the cys-
steines were located at the same protein regions as iniscussion
revious studies that have reported on the inhibition of
GL by pCMB, HgCl2, and NEM suggest one or several
ssential sulfhydryl groups in MGL structure [22, 23].
n the present study, the above-mentioned sulfhydryl-
pecific compounds were shown to inhibit the enzy-
atic hydrolysis of 2-AG in rat cerebellar membranes.
oreover, the NEM-sensitive site on the MGL-like en-
yme in rat cerebellar membranes was studied in more
etail by using NEM analogs with varying N-substitu-
ion in order to determine how N-substitution alters the
nhibitory activity of maleimides. NEM and its analogs
ave been broadly used for the modification of the cys-
eine sulfhydryl groups, which are generally considered
o be the most reactive groups in a protein. NEM has
lso been shown to react with functional groups other
han the SH group, for example the imidazole moiety of
istidine [24]. However, those non-SH reactions effec-
ively occur at only very high concentrations of NEM
100 mM) [25], which is ten times higher than the maxi-
um concentration used in the present study (10 mM).
he sulfhydryl moiety of cysteine interacts with the ole-
inic double bond of NEM to form a thioether [24]. This
eaction is also known as Michael addition. In the pres-
nt study, the lack of inhibition by succinimide strictly
ndicates that inhibition of MGL-like activity by malei-
ides occurs by the Michael addition reaction.
In the present study, MGL-like activity in rat cerebel-
ar membranes was inhibited by maleimide, NEM,
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653NPhM, NCM, NPrM, and MBTA with no significant dif-
ferences between their respecting IC50 values. How-
ever, hydrophilic NHM was approximately eight times
less potent than the above-mentioned maleimides.
NPyrM, the bulky and lipophilic maleimide, inhibited
MGL-like activity with approximately six times lower
IC50 value than NEM. N-Substitution in maleimides has
been reported to have no effect on thiol reactivity per
se [26]. However, the altered lipophilicity or steric hin-
drance caused by the N-linked maleimide side chains
may alter their biological effects. The observation that
increasing lipophilicity enhances the inhibitory activity
of maleimides on MGL suggests that a NEM-sensitive
site exists in a hydrophobic region of the enzyme.
There are six cysteine residues in the rat MGL cDNA
[8]. Although the constructed MGL model is only a
rough comparison model, the locations of the cysteines
can be predicted with a reasonable accuracy. In the rat
MGL sequence, Cys242 resides only three residues
away from Asp239, and, therefore, it is not surprising
to see it near the catalytic site in the 3D model. Assum-
ing that the core of MGL would share a similar tertiary
fold with the template, cysteines 32, 55, and 301 cannot
locate near the active site. However, Cys201 and
Cys208 are located in the structurally variable area and
the positions of these residues can only be roughly pre-
dicted. Interestingly, the only cysteine residue of the
chloroperoxidase template is in the sequence align-
ment located near Cys208 (Figure 2). According to the
model, the sulfhydryl groups of two cysteines (Cys32
and Cys201) reside on the surface of the enzyme,
whereas the sulfhydryl groups of Cys55, Cys208, and
Cys242 are buried within the protein structure. Cys-
teines 208 and 242 are located in the proximity of the
putative substrate binding site, suggesting a more lipo-
philic microenvironment for these sulfhydryl groups.
The substrate analog NAM was shown to be w380
times more potent than NEM as an inhibitor. The po-
tency and structural similarity of NAM with 2-AG indi-
cates that it binds to a sulfhydryl group within the sub-
strate binding site. Additionally, the ring-saturated
analog of NAM failed to inhibit MGL-like activity, prov-
ing that enzyme inhibition by NAM occurs through the
Michael addition reaction. Moreover, the enzyme activ-
ity was not restored after washing NAM-preincubated
membranes, indicating that the inhibition occurs
through covalent modification of the enzyme. Hypothe-
sized from the 3D model of rat MGL, either Cys242 or
Cys208 could be modified by maleimides, thus leading
to enzyme inactivation. However, the precise role of
these cysteines should be confirmed experimentally,
for example, by site-directed mutagenesis. The inhibi-
tion of MGL by maleimides could be due to simple ste-
ric hindrance, or it could cause a conformational
change in the enzyme. The fact that the enzyme activity
could not be abolished completely (remaining activity
w15%) by any of these maleimides may be explained
by the inhibition mechanism; maleimides bind to a cys-
teine located near to the catalytic triad not to the resi-
dues of the catalytic triad. The incomplete MGL inhibi-
tion by NEM was observed also by Sakurada and Noma
[17] when they inhibited MGL by NEM (2 mM) in plasma
membrane and cytosol fractions of rat adipocytes. The
remaining enzyme activity was 25% and 15%, respec-tively [17]. However, the possibility that 2-AG is inacti-
vated in rat cerebellar membranes by additional pres-
ently unknown enzymatic activity should also be taken
into consideration.
Many enzymes with a reactive sulfhydryl group have
been shown to be inhibited by NO reactive species [27].
In the current study, we determined the activity of the
MGL-like enzyme in the presence of NO donors GSNO,
CysNO, and SNP. However, no significant changes in
the enzyme activity were shown by any of these NO
donors. This result suggests that MGL-like activity is
not under NO regulation, a finding in agreement with a
previous study that demonstrated the inhibition of nitric
oxide synthase by nitro L-arginine methyl ester and
L-methylarginine had no effect on MGL activity in syn-
aptoneurosomes [28].
Significance
The present study shows that maleimides with bulky
hydrophobic N-substitution inhibit MGL-like enzyme
in rat-cerebellar-membrane preparation more effec-
tively than maleimides with hydrophilic or small
hydrophobic N-substituted groups. In addition, the
substrate analog NAM is a more potent inhibitor of
MGL-like activity than the rigid NPyrM. The relatively
high potency of NAM is most probably due to its
structural similarity with the natural MGL substrate
2-AG. These results indicate that the critical cysteine
residue lies within the lipophilic substrate binding
pocket. According to the 3D model of rat MGL, cys-
teines 242 and 208 reside in close proximity to the
putative 2-AG binding site, a finding that lets us hy-
pothesize that the enzyme inhibition would occur be-
cause of alkylation of either of these cysteines, thus
leading to steric hindrance of 2-AG binding at the
active site. This intriguing hypothesis needs to be
confirmed by further experiments, such as site-directed
mutagenesis studies. Despite covalent attachment of
maleimide compounds to a cysteine residue, the find-
ing that MGL or MGL-like activity is effectively inhib-
ited by NAM and maleimides with bulky hydrophobic
N-substitution may facilitate further efforts to develop
potent and selective MGL inhibitors. Such inhibitors
could offer a rational therapeutic approach in treating
certain pathological states, such as pain and neuroin-
flammation [29].
Experimental Procedures
Materials
2-AG was purchased from Cayman Chemical (Ann Arbor, Michi-
gan). N-ethylmaleimide (NEM), BSA (essentially fatty acid free), glu-
tathione, nimesulide, indomethacin, acetylsalicylic acid, and ibu-
profen were purchased from Sigma (St. Louis, Missouri). Maleimide,
N-cyclohexylmaleimide (NCM), N-hydroxymaleimide (NHM), N-phe-
nylmaleimide (NPhM), N-propylmaleimide (NPrM), succinimide,
para-chloromercuribenzoic acid (pCMB), HgCl2, diethyl dicarbox-
ylate (DEAD), and triphenylphosphine (Ph3P) were purchased from
Aldrich (Milwaukee, Wisconsin). 4-(N-maleimido)benzyl-α-trime-
thylammonium iodide (MBTA) and N-(1-pyrenyl) maleimide (NPyrM)
were obtained from Toronto Research Chemicals, Inc. (North York,
Ontario, Canada). Arachidonyl alcohol was purchased from Nu-
Chek-Prep, Inc. (Elysian, Minnesota). L-Cysteine and sodium nitro-
prusside (SNP) were obtained from Merck (Darmstadt, Germany).
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wFour-week-old male Wistar rats were used in these studies. All ani-
mal experiments were approved by the local ethics committee. The m
banimals lived in a 12 hr light/12 hr dark cycle (lights on at 0700 hr)
with water and food available ad libitum. The rats were decapitated c
m8 hr after lights on (1500 hr), and whole brains were removed,
dipped in isopentane on dry ice, and stored at −80°C. Membranes 
rwere prepared as previously described [30–32]. Briefly, cerebella
(minus brain stem) from eight animals were weighed and homoge- t
dnized in nine volumes of ice-cold 0.32 M sucrose with a glass Teflon
homogenizer. The crude homogenate was centrifuged at low speed s
c(1,000 × g for 10 min at 4°C), and the pellet was discharged. The
supernatant was centrifuged at high speed (100,000 × g for 10 min H
oat 4°C). The pellet was resuspended in ice-cold deionized water
and washed twice, and high-speed centrifugation was repeated. b
aFinally, membranes were resuspended in 50 mM Tris-HCl (pH 7.4)
with 1 mM EDTA and aliquoted for storage at −80°C. The protein p
concentration of the final preparation, measured by the Bradford
method [33], was 15 mg/ml−1. H
T
Synthesis L
The synthesis of N-arachidonylmaleimide (NAM) and N-arachi- a
donylsuccinimide (NAS) was achieved by reacting arachidonyl al- g
cohol with the appropriate imide, according to the modified Mitsu- Z
nobu reaction [34]. m
v
bN-Arachidonylmaleimide (NAM)
mPh3P (70 mg, 0.27 mmol) was dissolved in dry THF. The resulting
Aclear solution was cooled to –78°C. DEAD (47 mg, 0.27 mmol) was
oadded, and a yellow reaction mixture formed. Arachidonyl alcohol
c(110 mg, 0.38 mmol) was added, and the reaction mixture was
rstirred for 5 min, after which maleimide (30 mg, 0.31 mmol) was
tadded. The reaction mixture was kept at –78°C for 5 min after
twhich it was removed to ambient temperature and stirred over-
night. Progress of the reaction was monitored by TLC. The reaction
mixture was concentrated under vacuum and purified by flash D
chromatography on silica gel with petroleum ether/ethyl acetate T
(7:1) as an eluent. After purification, 50 mg of N-arachidonylmalei- a
mide was obtained (0.135 mmol, 44% yield, oil). 1H NMR (CDCl3): δ m
0.89 (t, J = 6.8 Hz, 3H), 1.29–1.37 (m, 8H), 1.58–1.62 (m, 2H), 2.04– c
2.10 (m, 4H), 2.80–2.84 (m, 6H), 3.52 (t, J = 7.3 Hz, 2H), 5.30–5.42 P
(m, 8H), and 6.68 (s, 2H). 13C NMR: δ 14.1, 22.6, 25.6 (3C), 26.7 (2C),
27.2, 28.1, 29.3, 31.5, 37.8, 127.6, 127.9, 128.2, 128.3, 128.4, 128.6, M
129.5, 130.5, 134.1 (2C), and 170.2 (2C). T
S
N-Arachidonylsuccinimide (NAS) B
The synthesis of NAS was performed as described above, starting [
from 26 mg succinimide (0.26 mmol) and yielding 40 mg (0.11 o
mmol, 42%, oil). 1H NMR (CDCl3): δ 0.89 (t, J = 7.5 Hz, 3H), 1.26– (
1.40 (m, 8H), 1.56–1.62 (m, 2H), 2.03–2.11 (m, 4H), 2.69 (s, 4H), 2.79– o
2.85 (m, 6H), 3.51 (t, J = 6.9 Hz, 2H), and 5.30–5.43 (m, 8H). 13C t
NMR: δ 14.1, 22.6, 25.6 (3C), 26.7, 26.8, 27.2, 27.3, 28.2 (2C), 29.3, p
31.5, 38.8, 127.6, 127.9, 128.2, 128.3, 128.4, 128.6, 129.5, 130.5, Q
and 177.2 (2C). q
c
GSNO and CysNO 2
S-Nitrosoglutathione (GSNO) and S-nitrosocysteine (CysNO) were u
synthesized from their respective thiols with acidified NaNO2, t
which was prepared by mixing 100 l sodium nitrite (100 mM) with m
100 l HCl (150 mM) and then adding 100 l reduced glutathione P
or L-cysteine (100 mM for both). Reactions were protected from M
light and allowed to proceed for 10 min at room temperature. Reac-
tion mixtures were neutralized with 150 l NaOH (100 mM) and a
immediately used in the experiments. Millipore-quality water was (
used throughout the study, and the assay buffer routinely con- t
tained 1 mM EDTA. The concentrations of RSNOs were determined f
by UV spectroscopy with previously published [35] values for the I
molar absorption coefficients () and absorption maxima (λmax). d
m
bEnzyme Assay
The experiments were carried out with preincubations (80 l, 30 r
tmin at 25°C) containing 10 g membrane protein, 44 mM Tris-HCl
(pH 7.4), 0.9 mM EDTA, 0.5% (wt/vol) BSA, and 1.25% (vol/vol)MSO as a solvent for inhibitors. The preincubated membranes
ere kept at 0°C just prior to the experiments. The incubations (90
in at 25°C) were initiated by adding 40 l of preincubated mem-
rane cocktail, giving a final volume of 400 l. The final volume
ontained 5 g membrane protein, 54 mM Tris-HCl (pH 7.4), 1.1
M EDTA, 100 mM NaCl, 5 mM MgCl2, 0.5% (wt/vol) BSA, and 50
M of 2-AG. At time points of 0 and 90 min, 100-l samples were
emoved from incubation, acetonitrile (200 l) was added to stop
he enzymatic reaction, and pH of the samples were simultaneously
ecreased to 3.0 with phosphoric acid (added to acetonitrile) to
tabilize 2-AG against acyl migration to 1(3)-AG. Samples were
entrifuged at 23,700 × g for 4 min at room temperature prior to
PLC analysis of the supernatant. Under these conditions, the rate
f arachidonic-acid formation was linear with respect to the mem-
rane protein concentration up to 10 µg (data not shown) as well
s to the 90 min incubation time (see [10]). During this incubation
eriod, around 40% of the substrate was consumed.
PLC Method
he analytical HPLC system consisted of a Merck Hitachi (Hitachi,
td., Tokyo) L-7100 pump, D-7000 interface module, L-7455 diode-
rray UV detector (190–800 nm, set at 211 nm), and L-7250 pro-
rammable autosampler. The separations were accomplished by a
orbax SB-C18 endcapped reversed-phase precolumn (4.6 × 12.5
m, 5 m) and column (4.6 × 150 mm, 5 m) (Agilent). The injection
olume was 50 l. A mobile phase mixture of 28% phosphate
uffer (30 mM, pH 3.0) in acetonitrile was used at a flow rate of 2.0
l/min−1. Retention times were 5.8 min for 2-AG, 6.3 min for 1(3)-
G, and 10.2 min for arachidonic acid. The relative concentrations
f 2-AG, 1(3)-AG, and arachidonic acid were determined by the
orresponding peak areas. This was justified by the equivalence of
esponse factors for the studied compounds and is supported by
he observation that the sum of the peak areas was constant
hroughout the experiments.
ata Analyses
he results from the enzyme inhibition experiments are presented
s mean ± SEM or mean ± SD of at least three independent experi-
ents performed in duplicate. Data analyses for the dose-response
urves were calculated as nonlinear regressions with GraphPad
rism 4.0 for Windows.
olecular Modeling
he amino acid sequence of rat MGL was retrieved from the
WISS-PROT/TrEMBL database (Q8R431) [36], and a subsequent
LAST search [37] was made from the Protein Data Bank (PDB)
38] to find close homologs for the sequence. The X-ray structure
f chloroperoxidase L (EC 1.11.1.10) from Streptomyces lividans
pdb1a88; chain A) [39] was chosen as the template for the process
f comparative modeling. The rat MGL sequence was aligned with
he template sequence, as well as with the sequences of bromo-
eroxidase A2 (EC 1.11.1.10; pdb1brt) [39], human MGL (TrEMBL:
96AA5), and mouse MGL (TrEMBL: O35678) with the multiple se-
uence alignment program Clustal W 1.82 [40]. Additionally, se-
ondary structures of rat MGL were predicted by the PSIPRED v
.3 algorithm [41]. The multiple sequence alignment was then man-
ally modified so that gaps were shifted to the loop regions, and
he secondary structures of the template and rat MGL were closely
atched (Figure 2). The CYSPRED [21] program, via the Predict-
rotein server [42], was used to predict disulfide bonds in the rat
GL structure.
The HOMOLOGY module of the InsightII v.2000 modeling pack-
ge (Accelrys, Inc.) was used to extract the aligned coordinates
see Figure 2) from the chloroperoxidase X-ray structure and apply
hem to the MGL model. The loops for the model were selected
rom the PDB by a random loop search procedure implemented in
nsightII. The coordinates of Gly100 and Gly172 in the chloroperoxi-
ase structure were skipped, and the resulting gaps in the MGL
odel were repaired simply by joining the chain ends of the neigh-
oring residues. Residue rotamers that severely clashed with other
esidues were changed into more favorable residues by utilizing
he InsightII rotamer library.
Finally, the resulting comparison model was subjected to energy
Inhibition of MGL by Maleimide Probes
655minimization by the SYBYL (v. 6.9.2) modeling program as follows:
(1) 50 iterations with the steepest descent method, keeping the
catalytic triad and the backbone atoms of the secondary structures
fixed; (2) 100 iterations with the conjugate gradient minimizer,
keeping the same aggregate as in the first step; and (3) 200 itera-
tions with the conjugate gradient minimizer, keeping only the cata-
lytic triad as an aggregate. In SYBYL, the Kollman All-Atom force
field with Kollman charges [43] was used for the minimization pro-
cedure. Subsequently, the hydroxyl group hydrogen atom of Ser122
was directed toward the NE2 nitrogen of His269.
For comparison, an automatic protein-structure prediction server
ROBETTA [44, 45] was used to construct a 3D model of rat MGL.
Also, the FUGUE program [46] that recognizes distant homologs
by sequence-structure comparison was utilized to see if the choice
of the template structure for rat MGL and the sequence alignment
by the program were comparable with our modeling work.
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